Publicacións en colaboración con investigadores/as de Hospital General de Ciudad Real (17)

2024

  1. Predicting the Length of Mechanical Ventilation in Acute Respiratory Disease Syndrome Using Machine Learning: The PIONEER Study

    Journal of Clinical Medicine, Vol. 13, Núm. 6

2022

  1. The PANDORA Study: Prevalence and Outcome of Acute Hypoxemic Respiratory Failure in the Pre-COVID-19 Era

    Critical Care Explorations, Vol. 4, Núm. 5, pp. E0684

2021

  1. Stratification for Identification of Prognostic Categories In the Acute RESpiratory Distress Syndrome (SPIRES) Score

    Critical Care Medicine, Vol. 49, Núm. 10, pp. E920-E930

2020

  1. Associated risk factors and outcomes of acute kidney injury in severe trauma: Results from the Spanish trauma ICU registry (RETRAUCI)

    Anaesthesia Critical Care and Pain Medicine, Vol. 39, Núm. 4, pp. 503-506

  2. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial

    The Lancet Respiratory Medicine, Vol. 8, Núm. 3, pp. 267-276

2019

  1. Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): An investigator-driven, open-label, randomized, noninferiority controlled trial

    Critical Care, Vol. 23, Núm. 1

2018

  1. Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia

    Clinical Microbiology and Infection, Vol. 24, Núm. 11, pp. 1213.e1-1213.e4

  2. Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database

    Critical Care, Vol. 22, Núm. 1

  3. Improved empirical antibiotic treatment of sepsis after an educational intervention: The ABISS-Edusepsis study

    Critical Care, Vol. 22, Núm. 1

  4. Is overall mortality the right composite endpoint in clinical trials of acute respiratory distress syndrome?

    Critical Care Medicine, Vol. 46, Núm. 6, pp. 892-899

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

  2. Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: Study protocol for a randomized controlled trial

    Trials, Vol. 17, Núm. 1

2015

  1. Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: Study protocol for a randomized controlled trial

    Trials, Vol. 16, Núm. 1

2014

  1. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

    BMC Infectious Diseases, Vol. 14, Núm. 1

2011

  1. Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus

    Chest, Vol. 139, Núm. 3, pp. 555-562

  2. Impact of obesity in patients infected with 2009 influenza A(H1N1)

    Chest, Vol. 139, Núm. 2, pp. 382-386

  3. Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain

    Respirology, Vol. 16, Núm. 1, pp. 78-85